PIK3CA Mutations
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors (NCT07383506) | Cogent Biosciences, Inc. | 2026-06-01 |
Track PIK3CA Mutations automatically
Every clearance here is in the API, with alerts when new ones post.